| http://www.w3.org/ns/prov#value | - For breast cancer, there was a slightly higher incidence among those on insulin glargine alone compared with those on non-glargine insulin (HR 1.33, 95% CI 0.69???2.56); this difference was non-significant.DiscussionIn this analysis of Scotland-wide data, we found no difference in the rate of total cancers or site-specific cancers between those exposed to insulin glargine therapy vs those not expo
|
